Studies with bioengineered Nisin peptides highlight the broad-spectrum potency of Nisin V.
about
Lanthipeptides: chemical synthesis versus in vivo biosynthesis as tools for pharmaceutical productionAdvances in the Microbiome: Applications to Clostridium difficile InfectionThe potential for emerging therapeutic options for Clostridium difficile infectionBioengineering of the model lantibiotic nisinBioengineered nisin A derivatives with enhanced activity against both Gram positive and Gram negative pathogensA bioengineered nisin derivative to control biofilms of Staphylococcus pseudintermediusIn Vitro Activities of Nisin and Nisin Derivatives Alone and In Combination with Antibiotics against Staphylococcus BiofilmsBacteriocin Gene-Trait matching across the complete Lactobacillus Pan-genome.In vivo activity of nisin A and nisin V against Listeria monocytogenes in mice.Saturation mutagenesis of lysine 12 leads to the identification of derivatives of nisin A with enhanced antimicrobial activity.Bactofencin A, a new type of cationic bacteriocin with unusual immunity.Efficacies of nisin A and nisin V semipurified preparations alone and in combination with plant essential oils for controlling Listeria monocytogenes.Antimicrobial activity of lactic acid bacteria in dairy products and gut: effect on pathogens.Production of multiple bacteriocins from a single locus by gastrointestinal strains of Lactobacillus salivarius.Salivaricin D, a novel intrinsically trypsin-resistant lantibiotic from Streptococcus salivarius 5M6c isolated from a healthy infant.Bioengineering of a Nisin A-producing Lactococcus lactis to create isogenic strains producing the natural variants Nisin F, Q and Z.Synergistic Nisin-Polymyxin Combinations for the Control of Pseudomonas Biofilm Formation.Saturation mutagenesis of selected residues of the α-peptide of the lantibiotic lacticin 3147 yields a derivative with enhanced antimicrobial activityThe dawning of a 'Golden era' in lantibiotic bioengineering.Bacterial resistance to cationic antimicrobial peptides.'Bac' to the future: bioengineering lantibiotics for designer purposes.Heterologous expression of thuricin CD immunity genes in Listeria monocytogenesInsights into the Mode of Action of the Sactibiotic Thuricin CD.Antibacterial activity of defensin PaDef from avocado fruit (Persea americana var. drymifolia) expressed in endothelial cells against Escherichia coli and Staphylococcus aureusGene encoded antimicrobial peptides, a template for the design of novel anti-mycobacterial drugs.Autoinduction Specificities of the Lantibiotics Subtilin and Nisin.A Bioengineered Nisin Derivative, M21A, in Combination with Food Grade Additives Eradicates Biofilms of Listeria monocytogenesAssessing the contributions of the LiaS histidine kinase to the innate resistance of Listeria monocytogenes to nisin, cephalosporins, and disinfectants.Intensive mutagenesis of the nisin hinge leads to the rational design of enhanced derivatives.Bioengineered nisin derivatives with enhanced activity in complex matrices.Nisin in Combination with Cinnamaldehyde and EDTA to Control Growth of Escherichia coli Strains of Swine Origin.Discovery of a novel lantibiotic nisin O from Blautia obeum A2-162, isolated from the human gastrointestinal tract.Evaluating the feasibility of lantibiotics as an alternative therapy against bacterial infections in humans.Multifaceted Defense against Listeria monocytogenes in the Gastro-Intestinal Lumen.
P2860
Q26748638-19D7316D-3C48-498A-823B-9603502DF707Q28066362-BC22F429-68F1-4424-A548-9A3C9CC8BB6BQ28082059-B089DA98-438D-4924-9FD7-E989C4D167BFQ28087616-46E23172-534C-4350-91E5-2144C3E51F15Q28484253-150F57E1-2CA0-4B69-B382-AF3618CF6C94Q28544703-0D7FA72E-4E9A-4369-9A40-892AE1FE9A88Q28834620-99BCE5F9-6175-4222-A45D-B65C63251555Q33799465-880C101C-8E08-4002-A699-32B9132FF2D1Q34572089-96797682-025B-4243-833C-72B942725DECQ34625915-F7B8C8AE-9F10-44AE-8E4B-8C4408D14D6CQ35028336-A8A21BC5-0CCD-410F-9A06-6CAF0DC1564CQ35221093-452BC5F4-5986-4F4F-A125-C97AAD790F24Q35229172-B52DAC74-ED5B-4853-8413-69C391278863Q35598605-6CD2183D-7968-4D98-B6E6-A581D1F1C5D8Q35665575-74AECC09-6F20-4D35-9D7C-11F92E455335Q37283902-077284FC-C571-4645-AD1F-A7C7AACB521AQ37366258-552EEA6C-9720-44A1-A1F2-5D27B39800F1Q37569003-6E4DA3F4-663C-4FDA-BC1A-3530B007AE74Q37811027-65081BC8-38F1-4580-87B9-AF6BA67CCDECQ38026594-44D3CE9E-FA93-402E-89F9-57A7A239D030Q38062005-05944B14-EC27-42E1-93CD-668B1139DC45Q41076238-195333F2-454E-4B80-96FF-588A66C2CD27Q41846338-0382B3E9-24A1-4EF7-BD19-87D8EBEDAE36Q41947986-59963F46-765C-40DA-861B-E6CAA5D9E6BCQ42085729-D987BB35-36A0-42CF-9174-D8589EA5DDAAQ42140925-2839D360-DFE2-47C1-8A8E-ECF3A07A6B12Q42362011-27C35A94-F670-4E30-9A38-74DDB3A88B87Q42558328-362F2821-AAFE-4746-912E-03AFA54A0197Q42735899-01A1505E-5918-4CFF-A74B-DE56D0E623F2Q42924568-6E2136AE-BA46-4617-ACAD-97AD30FC9174Q47159799-C493BDBD-836E-40CA-97DA-7F754B9417B5Q50251400-ED309F5F-4380-4898-BDA8-0E2B2F36795AQ51712533-BFBD17B9-B27A-4CB9-8972-E85DF8843A71Q52738903-C07FB7FB-D6E9-488F-94A9-80746B96E720
P2860
Studies with bioengineered Nisin peptides highlight the broad-spectrum potency of Nisin V.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Studies with bioengineered Nis ...... d-spectrum potency of Nisin V.
@en
Studies with bioengineered Nis ...... d-spectrum potency of Nisin V.
@nl
type
label
Studies with bioengineered Nis ...... d-spectrum potency of Nisin V.
@en
Studies with bioengineered Nis ...... d-spectrum potency of Nisin V.
@nl
prefLabel
Studies with bioengineered Nis ...... d-spectrum potency of Nisin V.
@en
Studies with bioengineered Nis ...... d-spectrum potency of Nisin V.
@nl
P2093
P2860
P50
P1476
Studies with bioengineered Nisin peptides highlight the broad-spectrum potency of Nisin V
@en
P2093
Karen Daly
Lisa Quigley
Paula M O'Connor
P2860
P304
P356
10.1111/J.1751-7915.2010.00184.X
P577
2010-07-01T00:00:00Z